Oxford Nanopore Technologies
Browse news and features about Oxford Nanopore Technologies – a company founded in 2005 to develop a disruptive, electronic, single-molecule sensing system based on nanopore science. The company’s novel, electronics-based DNA/RNA sequencing technology is now used in nearly 100 countries for a range of biological research applications.
-
Oxford Nanopore and Day Zero Diagnostics to develop new bloodstream infection diagnostics
Oxford Nanopore and Day Zero Diagnostics have announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.
-
G7 health summit highlights Oxfordshire’s thriving life sciences sector
The arrival of G7 health ministers to Oxford on Thursday 03 June will shine a spotlight on Oxfordshire’s considerable achievements in the life sciences sector.
-
Oxford Nanopore raises £84.4M in new capital
Oxford Nanopore Technologies has raised £84.4M in new capital from existing investors and new investors, including International Holdings Company (IHC) and RPMI Railpen.
-
Oxford Nanopore partners with UK Gov on new generation COVID-19 test
The test is fully scalable and designed to enable both high-volume screening and rapid, local testing, and results can be obtained in under two hours.
-
Oxford Nanopore announces £48.4M in new capital to support ongoing innovation
Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital from new investors and existing shareholders in EMEA, US and Asia.
-
Oxford Nanopore sequencing technology supports COVID-19 pandemic efforts
Oxford Nanopore is working with public health laboratories around the world, and researchers in related areas, to support the current COVID-19 pandemic.
-
Oxford Nanopore Technologies raises £109.5m in investment and share sales
Oxford Nanopore Technologies raises £109.5m in investment and share sales with £29.3m of new capital and £80.2m from sale of secondary shares.